Cargando…

Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial

BACKGROUND: Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung cancer (ES-NSCLC). SABR is able to obtain high rates of local control with low rates of symptomatic toxicity in this patient populat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palma, David A., Chen, Hanbo, Bahig, Houda, Gaede, Stewart, Harrow, Stephen, Laba, Joanna M., Qu, X. Melody, Rodrigues, George B., Yaremko, Brian P., Yu, Edward, Louie, Alexander V., Dhaliwal, Inderdeep, Ryerson, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905060/ https://www.ncbi.nlm.nih.gov/pubmed/31829203 http://dx.doi.org/10.1186/s12885-019-6392-8

Ejemplares similares

ChILD – Children's interstitial lung disease
Publicado: (2018)

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
por: Spagnolo, Paolo, et al.
Publicado: (2021)

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD)
por: Jung, Flora, et al.
Publicado: (2023)

Surfactant Metabolism Dysfunction and Childhood Interstitial Lung Disease (chILD)
por: McFetridge, Lynne, et al.
Publicado: (2009)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs)
por: Mishra, Smriti, et al.
Publicado: (2018)

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians
por: Althobiani, Malik, et al.
Publicado: (2021)

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
por: Fujii, Hiroaki, et al.
Publicado: (2023)

Laying the ground for research of interstitial lung disease in our country: ILD India registry
por: Singh, Virendra, et al.
Publicado: (2014)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

High resolution computed tomography patterns in interstitial lung disease (ILD): prevalence and prognosis
por: Almeida, Renata Fragomeni, et al.
Publicado: (2020)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
por: Patel, Avignat S., et al.
Publicado: (2023)

Impact of ILD-Specific Therapies on Perioperative Course in Patients with Progressive Interstitial Lung Disease Undergoing Lung Transplantation
por: Munker, Dieter, et al.
Publicado: (2023)

Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): facilitators and barriers
por: Reigada, C, et al.
Publicado: (2017)

Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype
por: Nili, Mona, et al.
Publicado: (2022)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2020)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2022)

Track reconstruction at the ILC: the ILD tracking software
por: Gaede, F, et al.
Publicado: (2014)

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
por: De Sadeleer, Laurens J., et al.
Publicado: (2020)

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
por: Mehta, Puja, et al.
Publicado: (2022)

Response to “Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)” by Joseph et al.
por: Parikh, Raj, et al.
Publicado: (2023)

An Unusual Association of Idiopathic Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) With Interstitial Lung Disease (ILD)
por: Saha, Shubhashis, et al.
Publicado: (2023)

Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses
por: Fields, Aislin, et al.
Publicado: (2023)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD
por: Furukawa, Hiroshi, et al.
Publicado: (2015)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Vitamin D levels are prognostic factors for connective tissue disease associated interstitial lung disease (CTD-ILD)
por: Gao, Yujuan, et al.
Publicado: (2020)

Nasal High-Flow (NHF) Improves Ventilation in Patients with Interstitial Lung Disease (ILD)—A Physiological Study
por: Bräunlich, Jens, et al.
Publicado: (2023)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [(18)F]FDG PET and CT perfusion: a prospective exploratory clinical study
por: Yang, Dae-Myoung, et al.
Publicado: (2021)

Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
por: Khedoe, Padmini, et al.
Publicado: (2020)

Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China
por: Xiaohong, Xie, et al.
Publicado: (2021)

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
por: Cao, Heng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a0f1pstfvppa9dhfhn5eos4g1v